Skip to search.
 TSX Up 0.00% TSX Ventures Up 0.58%

ZIOPHARM Oncology, Inc. (ZIOP)

-NasdaqCM
6.85 Up 0.03(0.44%) May 5, 4:00PM EDT
Prev Close:6.82
Open:6.88
Bid:6.48 x 200
Ask:7.24 x 200
1y Target Est:6.00
Beta:2.46121
Earnings Date:May 6 - May 9 (Est.)
Day's Range:6.66 - 7.10
52wk Range:4.56 - 14.93
Volume:1,827,327
Avg Vol (3m):2,578,520
Market Cap:892.02M
P/E (ttm):N/A
EPS (ttm):-0.96
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ZIOPUp 0.44%892.02M
IMGNDown 4.54%512.79M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):204.87
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-0.39
Quarterly EPS Est (Mar-16) :-0.08
Mean Recommendation*:3.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

ZIOPHARM Oncology, Inc., a biotechnology company, focuses on acquiring, developing, and commercializing a portfolio of cancer therapies that address unmet medical needs through synthetic immuno-oncology. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback